Return to homepagePandemic Pact

Vaccine Data CoLab Phase 2: Improving COVID-19 vaccine uptake, with a view to build resilient health systems for future shocks

  • Funded by Foreign, Commonwealth & Development Office (FCDO)
  • Total publications:0 publications

Grant number: GB-GOV-1-301168-114

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $2,333,167.42

  • Funder

    Foreign, Commonwealth & Development Office (FCDO)

  • Principal Investigator

    N/A

  • Research Location

    United Kingdom

  • Lead Research Institution

    DT Global International Development UK Ltd

  • Research Priority Alignment

    N/A

  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Vaccine/Therapeutic/ treatment hesitancy

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Phase 2 of the Vaccine Data CoLab will focus on catalysing COVID-19 vaccine uptake, with a view to build resilient health systems for future shocks. This approach moves beyond vaccine supply and works to provide data on the specific hesitancies and access barriers communities face. This requires moving from a global to a hyperlocal and targeted approach taking into account unique contexts and local planning and decision making for more effective behaviour change campaigns and vaccine strategies.